144 related articles for article (PubMed ID: 32503816)
1. Oral Methioninase for Covid-19 Methionine-restriction Therapy.
Hoffman RM; Han Q
In Vivo; 2020 Jun; 34(3 Suppl):1593-1596. PubMed ID: 32503816
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.
Ahmed-Belkacem R; Sutto-Ortiz P; Guiraud M; Canard B; Vasseur JJ; Decroly E; Debart F
Eur J Med Chem; 2020 Sep; 201():112557. PubMed ID: 32563813
[TBL] [Abstract][Full Text] [Related]
3. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
Saul S; Einav S
ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
[TBL] [Abstract][Full Text] [Related]
4. High-resolution structures of the SARS-CoV-2 2'-
Rosas-Lemus M; Minasov G; Shuvalova L; Inniss NL; Kiryukhina O; Brunzelle J; Satchell KJF
Sci Signal; 2020 Sep; 13(651):. PubMed ID: 32994211
[TBL] [Abstract][Full Text] [Related]
5. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
6. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Andreou A; Trantza S; Filippou D; Sipsas N; Tsiodras S
In Vivo; 2020 Jun; 34(3 Suppl):1567-1588. PubMed ID: 32503814
[TBL] [Abstract][Full Text] [Related]
8. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
Dal Moro F; Livi U
Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
[No Abstract] [Full Text] [Related]
9. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA.
Encinar JA; Menendez JA
Viruses; 2020 May; 12(5):. PubMed ID: 32397643
[TBL] [Abstract][Full Text] [Related]
10. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
McGowan EM; Haddadi N; Nassif NT; Lin Y
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
[TBL] [Abstract][Full Text] [Related]
11. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
Abbasi J
JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
[No Abstract] [Full Text] [Related]
12. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
Benani A; Ben Mkaddem S
Front Immunol; 2020; 11():1841. PubMed ID: 32793246
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of RNA cap modification by SARS-CoV-2.
Viswanathan T; Arya S; Chan SH; Qi S; Dai N; Misra A; Park JG; Oladunni F; Kovalskyy D; Hromas RA; Martinez-Sobrido L; Gupta YK
Nat Commun; 2020 Jul; 11(1):3718. PubMed ID: 32709886
[TBL] [Abstract][Full Text] [Related]
15. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
[TBL] [Abstract][Full Text] [Related]
16. Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series.
Fu D; Cao R; Zhao L; Li W; Zhong W; Wen J
Crit Care; 2020 Sep; 24(1):578. PubMed ID: 32977854
[No Abstract] [Full Text] [Related]
17. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
Theoharides TC
Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
[No Abstract] [Full Text] [Related]
18. Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia.
Bou Khalil R
Med Hypotheses; 2020 Sep; 142():109798. PubMed ID: 32413699
[No Abstract] [Full Text] [Related]
19. Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
Loscocco GG
Int J Hematol; 2020 Jul; 112(1):125-126. PubMed ID: 32474804
[No Abstract] [Full Text] [Related]
20. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
